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Abstract The evolutionary speed and the consequent
immune escape of H3N2 inﬂuenza A virus make it an
interesting evolutionary system. Charged amino acid resi-
dues are often signiﬁcant contributors to the free energy of
binding for protein–protein interactions, including anti-
body–antigen binding and ligand–receptor binding. We
used Markov chain theory and maximum likelihood esti-
mation to model the evolution of the number of charged
amino acids on the dominant epitope in the hemagglutinin
protein of circulating H3N2 virus strains. The number of
charged amino acids increased in the dominant epitope B
of the H3N2 virus since introduction in humans in 1968.
When epitope A became dominant in 1989, the number of
charged amino acids increased in epitope A and decreased
in epitope B. Interestingly, the number of charged residues
in the dominant epitope of the dominant circulating strain
is never fewer than that in the vaccine strain. We propose
these results indicate selective pressure for charged amino
acids that increase the afﬁnity of the virus epitope for water
and decrease the afﬁnity for host antibodies. The standard
PAM model of generic protein evolution is unable to
capture these trends. The reduced alphabet Markov model
(RAMM) model we introduce captures the increased
selective pressure for charged amino acids in the dominant
epitope of hemagglutinin of H3N2 inﬂuenza (R
2[0.98
between 1968 and 1988). The RAMM model calibrated to
historical H3N2 inﬂuenza virus evolution in humans ﬁt
well to the H3N2/Wyoming virus evolution data from
Guinea pig animal model studies.
Keywords Inﬂuenza   Virus evolution   Pepitope
Introduction
Inﬂuenza A virus causes annual global epidemics resulting
in severe morbidity and mortality. The dominant circulat-
ing virus today is the H3N2 virus, which emerged in 1968
and is deﬁned by two kinds of surface glycoproteins: H3
hemagglutinin and N2 neuraminidase. It is currently
believed that hemagglutinin is relevant to virus attachment
and entry into the cell, while neuraminidase facilitates
virus release (Frank 2002). Hemagglutinin also plays a
central role in the process of immuno escape, in which the
antibodies mainly attack ﬁve epitopes, denoted as epitopes
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DOI 10.1007/s00239-010-9405-4A–E, on the surface of the hemagglutinin protein (Mun ˜oz
and Deem 2005; Macken et al. 2001). Because of antigenic
changes through time, inﬂuenza vaccines are redesigned
each year to provide improved protection against evolved
circulating strains. The efﬁcacy of the annual vaccine is
variable due to the escape mutation of the inﬂuenza virus
(Smith et al. 1999), especially mutation at the ﬁve epitopes
on the hemagglutinin (Gupta et al. 2006).
By analyzing the results of over 50 epidemiological
studies of H3N2 inﬂuenza during the period 1968–2004
(Gupta et al. 2006; Sun and Deem 2009; Zhou et al. 2009;
Pan and Deem 2009) showed that the escape mutation of
inﬂuenza A virus can be measured by pepitope, the proportion
of mutated amino acids in the dominant epitope of hemag-
glutinin,wherethedominantepitopeisdeﬁnedastheepitope
with the largest such proportion among the ﬁve epitopes.
Compared with psequence, the proportion of mutated amino
acids in the whole sequence of hemagglutinin, and the ferret
antisera assays, pepitope between vaccine strains and domi-
nant circulating strains in the same ﬂu season correlated
better with the vaccine efﬁcacies in the northern hemisphere
(Gupta et al. 2006). Therefore, pepitope is an appropriate
measurement for the antigenic distances between vaccine
strains and dominant circulating strains. With the deﬁnition
ofthedominantepitope,theescapemutationatthedominant
epitope induces the largest antigenic distance between vac-
cine strains and dominant strains, and endows the dominant
epitope with the immunodominance.
In Gupta et al.’s (2006) model, which correlates well
with vaccine efﬁcacy in humans, every mutated amino acid
is assigned the same weight. However, free energy calcu-
lations suggest that different amino acid substitutions have
different contributions to the escape from the immune
pressure. In general, the calculated differences in binding
free energy DDG ¼ DGmutated   DGwildtype are different for
different mutations, where DGmutated and DGwildtype denote
binding free energy between two proteins one of which has
and does not have a point mutation, respectively. For the
experimentally measured difference in binding free energy
DDG between human growth hormone (hGH) and its ﬁrst
bound receptor (hGHbp), individual alanine substitutions
of hydrophobic amino acids on the epitope of hGHbp
induced the largest increase in DDG, followed by charged
amino acids (Clackson and Wells 1995). Nevertheless,
we show that charged amino acids correlate more
strongly with viral evolution (Tables 3, 4). Nakajima et al.
(2007) found that the majority of escape mutations of H3
hemagglutinin of the strain A/Kamata/14/91 were the
mutations that introduce charged amino acids, and that the
frequency of selected mutations to charged residues
was signiﬁcantly higher than that expected by random
chance. A related study by Smith et al. (2004) found a
similar over-representation of mutations to charged amino
acids in the evolution of inﬂuenza.
We here consider the effect of different physical prop-
erties on the escape from immune pressure. We focus on
the charged amino acids in the epitopes. These amino acids
are strongly hydrophilic, and they reduce the tendency of
antibodies to bind to hemagglutinin. Charged amino acids
play a critical role in protein–protein interaction by creat-
ing salt bridges and salt bridge networks. Charged amino
acids introduce speciﬁcity in binding (Sinha et al. 2002).
Amino acid substitutions involving charged residues in the
vicinity of receptor-binding region of HA affect the bind-
ing afﬁnity between HA and its receptor (Kaverin et al.
2000). The evolution of charged amino acids, therefore,
may provide useful information on viral escape from
antibody pressure. A discussion of charge evolution in
proteins has been given by Leunissen et al. (1990), who
observed a large variance in the evolutionary trends among
different protein families. Here we use stochastic methods
to model the evolution of charged amino acids on the
epitopes of H3 hemagglutinin strains collected from
humans since 1968.
The metaanalysis of 50 epidemiological human vaccine
efﬁcacy studies shows that the single dominant epitope is
the critical region that determines the epidemiological
vaccine efﬁcacy (Gupta et al. 2006). There are ﬁve non-
overlapping epitopes on the surface of H3 HA molecule,
namely epitope A–E, to which different sets of antibodies
bind. In each epitope, the p value is deﬁned as the fraction
of mutated amino acids (Gupta et al. 2006). The dominant
epitope is deﬁned as the epitope with the greatest p value.
The greatest p value is pepitope. Epidemiological data on the
vaccine efﬁcacies in 18 previous ﬂu seasons when H3N2
subtype was dominant were collected from approximately
50 studies (Gupta et al. 2006). The identities of the vaccine
strains and dominant circulating strains were also obtained
to calculate pepitope. H3N2 vaccine efﬁcacy correlates with
pepitope with R
2 = 0.81. This strong correlation shows that
pepitope deﬁned by the single dominant epitope is a quan-
titative deﬁnition of antigenic distance. Importantly, the
pepitope calculated from the dominant epitope correlated
better with vaccine efﬁcacy than did antigenic distance
including all HA amino acids (Gupta et al. 2006).
The results of (Sun et al. 2006) show that subdominant
epitopes are not the critical regions for vaccine efﬁcacy. In
an effort to improve the deﬁnition of antigenic distance,
four modiﬁcations of the deﬁnition of antigenic distance
were tested for their ability to improve the correlation with
vaccine efﬁcacy: (1) incorporating p values from sub-
dominant epitopes, (2) distinguishing conservative and non-
conservative amino acids mutations, (3) mutations in amino
acids adjacent to the epitopes, and (4) the calculation of
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modiﬁcations of the deﬁnition of antigenic distance,
including use of subdominant epitope p values, all failed to
substantially improve the correlation with vaccine efﬁcacy
data in the years 1971–2004. These results motivate our
focus on the dominant epitiope in the present analysis.
The reduced alphabet Markov model (RAMM) descri-
bed in this paper is an amino acid substitution model. It is
built from the H3 hemagglutinin strains circulating in
1972–1987 when epitope B was the dominant epitope. This
time span is shortly after the emergence of H3N2 virus in
1968, and this newly emerged virus subtype needed some
time to adapt to host immune system, because emergence
of new subtypes such as H2N2 in 1957 and H3N2 in 1968
went with Asian ﬂu and Hong Kong ﬂu outbreaks, indi-
cating that subtypes like H3N2 were more virulent in the
beginning and less adaptive to human. Further, the phylo-
genetic tree of H3N2 also shows that H3N2 evolved faster
at the very beginning than in the later stage (Smith et al.
2004). So the pattern of evolution illustrates the escape
mutation of the virus before substantial adaptation to host
immune system was developed. Because the sequence
database has been derived from patient samples and cate-
gorized by antigenic strain and date of collection, the
human data do not necessarily reﬂect ﬁxed variants, but,
rather, snapshots along an evolutionary continuum.
Mutations of amino acids in different positions in the
epitope are viewed as independent and identical Markov
chains, whose parameters are the transition matrix P or the
instantaneous rate matrix Q. Markov models of protein
evolution include the point accepted mutation (PAM)
model (Dayhoff et al. 1978) and the block substitution
matrix (BLOSUM) model (Henikoff and Henikoff 1992).
These models are derived by counting mutations in aligned
amino acid sequences, and this approach provides the
transition matrices P(t) of a Markov chain in a period of
evolutionary time t. Adachi and Hasegawa (1996) intro-
duced the maximum likelihood method to estimate the
elements of the transition matrix, and maximum likelihood
was also employed to estimate the evolutionary time
t when ﬁxing the transition matrix P(t) (Mu ¨ller and Ving-
ron 2000). The instantaneous rate matrix Q was calculated
from the Laplace transform of P(t) (Mu ¨ller and Vingron
2000;M u ¨ller et al. 2002). For a review of applications to
2000, see (Thorne 2000). Some recent studies estimated the
effect of possible multiple mutations at the same position
within evolutionary time t (Veerassamy et al. 2003; Kosiol
and Goldman 2005). The instantaneous rate matrix has
been estimated from observed frequencies of 20 amino
acids (Goldman and Whelan 2002).
The transition matrices P and the instantaneous rate
matrices Q of most previous models are 20 9 20 matrices
trained by analyzing databases with numerous alleles in
many taxa. In the present case, the training data are limited,
which can cause overﬁtting and introduce large errors to
the ﬁt model. One way to circumvent this difﬁculty is to
decrease the number of parameters: 20 amino acids may be
classiﬁed into several groups with similar biophysical
properties. Here we grouped 20 amino acids as 5 charged
amino acids and 15 uncharged amino acids.
To test whether the mathematical models can be applied
to data outside of the existing human data, we investigated
their relevance to animal models of inﬂuenza infection.
Guinea pigs have been shown to be infected with una-
dapted H3N2 strains. In most cases, the infection is limited
to the upper respiratory tract, causes little apparent mor-
bidity, and can be spread to cage mates via aerosol (Lowen
et al. 2006). As part of our analysis of the pepitope calcu-
lations, we developed additional evolutionary data derived
through analysis of progeny viruses in animal model sys-
tems. Interestingly, the pattern of variations in the Guinea
pig infection correlated well with the predictions of the
model and with the human evolutionary data.
Materials and Methods
We deﬁned the charged amino acids as {Asp, Glu, Arg,
Lys, His}. Historical sequence data indicated that the
number of charged residues increased continually on the
dominant epitope of the hemagglutinin of the circulating
H3N2 strains in Fig. 1, except for the data in the year
1996–1997 which was presumably a continuation of the
decreasing trend in the charge of epitope B since 1993. The
vaccine strains in Fig. 2 also had increasing numbers of
charged amino acids in a period of time without epitope
shift. The charge in the dominant epitope sometimes
stopped increasing, which means the charge saturated.
Moreover, since the observed dominant epitope in a given
year was either epitope A or epitope B, we deﬁned the
subdominant epitope as the epitope in the set {epitope A,
epitope B} other than the dominant one. Figures 1 and 2
also show that the number of charged residues decreased in
the subdominant epitope in both the circulating strains and
the vaccine strains. For vaccine strains and circulating
strains collected in 19 years, vaccine efﬁcacies in each year
had a strong correlation (R
2 = 0.81) with the pepitope in that
year (Gupta et al. 2006), but R
2 decreased quickly if we use
the weighted sum of pepitope and pepitope in previous years
(Pan and Deem, unpublished data). Therefore we treated
the immune escape of the virus as a Markov process (Minin
and Suchard 2008). Additionally, since there is limited
information on the correlation between different positions
on a given epitope, we assumed that the mutations at dif-
ferent positions on the epitope followed identical and
independent Markov chains.
92 J Mol Evol (2011) 72:90–103
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and the strains deposited in the GenBank database were
collected in 18 years between 1968 and 2003 and listed in
Table 1, where the numbers of charged amino acids are
presented as number for the dominant circulating strain and
the average number for the circulating strains in GenBank
database in the same year (Gupta et al. 2006). These data
were also plotted (Figs. 1, 3). The dominant epitope was
epitope A in the 1971 strain, epitope B in the {1972, 1973,
1975, 1984, 1985, 1987} strains, epitope A in the {1989,
1992, 1993, 1994, 1995} strains, and epitope B in the
{1996, 1997, 1998, 1999, 2001, 2003} strains. All the
strains except the 1971 strain fell into three multi-year time
intervals deﬁned by unchanged dominant epitopes. The
numbers of charged amino acids on the dominant epitopes
of each strain were counted and utilized. The total number
of charged amino acid on a certain epitope, Nc, was mod-
eled by a binomial distribution with probability
PrfNc ¼ ng¼
N
n
  
Pn
c t j  ;d1 ðÞ 1   Pc t j  ;d1 ðÞ ½ 
N n ð1Þ
with the mean number of amino acids in the epitope equal
to NPc t j  ;d1 ðÞ , where N was the total number of amino
acids on the epitope.
Discrete-Time Markov Chain
We ﬁrst applied a discrete-time Markov chain using 1 year
as the time unit because the available data are the strains
deposited in databases with 1-year time resolution. The
probability distribution was deﬁned as p t ðÞ¼ Pc t ðÞ ; ð
Pu t ðÞ Þ¼ Pc t ðÞ ;1   Pc t ðÞ ðÞ with the initial value
Pc0;1   Pc0 ðÞ , where Pc and Pu were the probabilities that
a charged amino acid and an uncharged amino acid existed
in a given position on the dominant epitope. Following this
deﬁnition, the transition matrix is a 2 9 2 matrix, taking
parameters that describes the evolutionary process. We
chose the mutation probability for each position,  , and the
bias for mutation to charged amino acids from charged or
uncharged amino acids, d1 and d2, respectively, to char-
acterize the virus evolution model discussed in this paper.
Thus, the transition matrix is
P ¼ 1     ðÞ 10
01
  
þ   acc acu
auc auu
  
ð2Þ
with acc ¼ 5
20 þ d1;acu ¼ 15
20   d1;auc ¼ 5
20 þ d2;auu ¼ 15
20  
d2; where istheaminoacidsubstitutionrate(thenewamino
acid could be identical to the original amino acid); and
acc;acu;auc, and auu are the conditional probabilities that a
chargedresiduemutatedtoachargedresidue,achargedresidue
mutatedtoanunchargedresidue,anunchargedresiduemutated
to a charged residue, and an uncharged residue mutated to an
unchargedresidue,respectively,ifthesubstitutionoccurred.
The parameters d1 and d2 were the bias for the probability
that a charged amino acid mutated to a charged amino acid,
an uncharged amino acid mutated to a charged amino acid,
respectively.Underthefurtherassumptionthatd1 ¼ d2 ¼ d,
the probability distribution in year t is
Pc t j  ;d ðÞ ;Pu t j  ;d ðÞ ðÞ ¼ ð Pc0;1  Pc0ÞPt
¼ð Pc0;1  Pc0ÞQ 1DtQ
¼
 
1
4
ð1þ 4d  1    ðÞ
t
1þ 4d  4Pc0 ðÞ Þ ;1  Pc t j  ;d ðÞ Þ
ð3Þ
where the matrix Q was invertible and the matrix D was
diagonal.
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123Continuous-Time Markov Chain
Besides the discrete-time Markov chain, the continuous-
time Markov chain was also commonly employed in sev-
eral bio-related ﬁelds including the estimation of residue
mutation rates (Tseng and Liang 2006). In the continuous-
time Markov chain, the transition rate matrix Q is ﬁrst
deﬁned describing the evolution of probability distribution
in a inﬁnitesimal time interval, with Q1 = 0, where 1 is a
column vector with all the elements equal to unity. The
transition matrix is
P t ðÞ¼ Pcc t ðÞ Pcu t ðÞ
Puc t ðÞ Puu t ðÞ
  
¼ exp Qt ðÞ ð 4Þ
with the probability distribution at year t was again deﬁned
as p t ðÞ¼ Pc t ðÞ ;Pu t ðÞ ðÞ ¼ p 0 ðÞ P t ðÞ with the initial
probability distribution p 0 ðÞ ¼Pc0;1   Pc0 ðÞ . And if the
Markov chain contains ﬁnite states, the Kolmogorov
backward equation (KBE)
d
dt
P t ðÞ¼QP t ðÞ ð KBEÞð 5Þ
holds.
For the evolution process of charged amino acid, the
Q matrix was deﬁned as
Q ¼
 k1 k1
k2  k2
  
k1;k2  0: ð6Þ
The solution for the transition matrix exp Qt ðÞ was
Pcc t ðÞ¼
k2
k1 þ k2
þ
k1
k1 þ k2
e  k1þk2 ðÞ t
Pcu t ðÞ¼
k1
k1 þ k2
 
k1
k1 þ k2
e  k1þk2 ðÞ t
Puc t ðÞ¼
k2
k1 þ k2
 
k2
k1 þ k2
e  k1þk2 ðÞ t
Puu t ðÞ¼
k1
k1 þ k2
þ
k2
k1 þ k2
e  k1þk2 ðÞ t:
The term Pc is given by
Pc t j k1;k2;Pc0 ðÞ ¼
k2
k1 þ k2
þ Pc0  
k2
k1 þ k2
  
e  k1þk2 ðÞ t:
ð7Þ
Maximum Likelihood Estimation
The maximum likelihood estimation method optimizes the
parameters in a given parametric form by maximizing the
log-likelihood function with the deﬁnition l h j x ðÞ ¼
lnP x j h ðÞ . The observed data x ¼ x1;x2;...;xm ðÞ are
usually independent, therefore the maximum likelihood
function is l h j x ðÞ ¼
Pm
k¼1 lnP xk j h ðÞ . In our model, the
data xk ¼ n;t ðÞ in different years were assumed to be
independent, where n was the number of charged amino
acids, t was the time in years, and the parameter set was
h ¼  ;d;Pc0 ðÞ . From the relationship between the total
number of charged amino acids and the probability distri-
bution at each position (1), the maximum likelihood
equation was written as
l  ;d;Pc0 j x ðÞ ¼
X m
k¼1
lnP xk j h ðÞ
¼
X m
k¼1
ln
N
nk
  
þ
X m
k¼1
nlnPc tk j  ;d;Pc0 ðÞ
þ
X m
k¼1
N   n ðÞ ln 1   Pc tk j  ;d;Pc0 ðÞ ½ 
ð8Þ
with the expression of Pc in (3).
The maximum likelihood function was maximized by
solving the following equations
o
o l  ;d;Pc0 j x ðÞ ¼ 0
o
odl  ;d;Pc0 j x ðÞ ¼ 0
o
oP0 l  ;d;Pc0 j x ðÞ ¼ 0
8
<
:
ð9Þ
The numerical solution was identical to that of the least
square ﬁt to the ﬁrst two signiﬁcant ﬁgures. We note that
solutions of (9) were not ill-conditioned while the
nonlinear ﬁtting algorithm for (3) led to ill-conditioned
Jacobians.
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Fig. 3 Average number of charged amino acids for each year on the
epitope A and epitope B of the strains deposited in the GenBank
database from 1971 to 2003. The curves in this ﬁgure are smoother
than those in Fig. 1 due to the averaging over database strains. The
difference in the numbers of charged amino acids between this ﬁgure
and Fig. 1 is smaller than one for most years
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The Guinea pig model of human inﬂuenza infection was
adopted to model the process of infection and reinfection
(Lowen et al. 2006). A sample of A/Wyoming/2003
(H3N2) was obtained from the Centers for Disease Control
and Prevention (CDC). Sequence analysis of multiple
plaque isolates from the CDC virus demonstrated that the
sample contained a mixture of viruses with several hem-
agglutinin (HA) sequences, all in close agreement with the
A/Wyoming/03/2003 sequence reposited in GenBank
(accession number AAT08000). An isolate (WyB4) rep-
resenting the dominant HA sequence contained within the
CDC virus mixture was puriﬁed and propagated.
In the ﬁrst infection experiment, four immunologically
naı ¨ve Guinea pigs were inoculated with the CDC virus
mixture to model virus evolution in the absence of robust
immunity. Three days following inoculation, progeny
virus were puriﬁed from nasal washes for sequence anal-
ysis of the HA genes. After a recovery period of 28 days,
two of the animals were reinfected with the CDC virus
mixture to model virus escape in the presence of increased
immune pressure. Nasal washes were collected after 3
days, progeny virus isolated, and HA gene sequences
analyzed. In a second infection experiment, six naı ¨ve
Guinea pigs were inoculated with the puriﬁed WyB4
isolate. Again, virus progeny were puriﬁed from nasal
wash samples for HA sequence analysis. In a third
infection experiment, Guinea pigs were inoculated with
three immunizations of recombinant Wyoming HA protein
having the same sequence as the WyB4 isolate. After the
animals had mounted robust immune responses, they were
challenged with either WyB4 or the CDC virus mixture.
Progeny virus were isolated from nasal washes for HA
gene sequence analyses.
Results
Charge Increases in the Dominant Epitope
The parameters obtained by the ﬁtting algorithm for the
ﬁrst time interval (epitope B was dominant, from 1972 to
1987) were h
T ¼  ;d;Pc0 ðÞ ¼ 0:207;0:113;0:0937 ðÞ with
the square of the correlation coefﬁcient between observa-
tions and the model R
2 = 0.98. The mathematical details
are given in Supplementary Material. Here the transition
matrix was
P ¼ 0:868 0:132
0:075 0:925
  
: ð10Þ
We plotted the observed data and the data predicted by
the model with the parameters ﬁxed by maximum
likelihood estimation in Fig. 4.W eﬁ t  and d to the data
in the range 1972–1987 and used these values for all years.
We ﬁt the value of Pc0 in the range 1972–1987 and found it
equal to the data point at 1972. For other intervals we used
the observed initial values.
The model parameters here yielded the average number
of point mutations in epitope B ¼ 19N =20 ¼ 4:07, and
the observed numbers of point mutation in epitope B dur-
ing 1 year were: 1971–1972, 4; 1972–1973, 6; 1984–1985,
0. Those are all the available 1-year time spans in the
training data, and this model falls inside the standard error
of the actual annual mutation rates on the dominant epi-
topes. That d = 0.11 showed that the conditional proba-
bility that a charged residue mutated to a charged residue
was 0.36 while the probability that an uncharged residue
mutated to an uncharged residue was 0.64. The observed
number of charged amino acids on epitope B in 1972 was
2, and corresponding Pc0 ¼ 2=21   0:095, which agrees
well with the ﬁt value Pc0 ¼ 0:094.
We also obtained all the strains deposited in the Gen-
Bank database that were collected in the same year as a
circulating strain existed. The numbers of charged amino
acids Nc ¼ NPc t j  ;d;Pc0 ðÞ were counted for each year
as the mean value of the numbers of charged amino acid on
the dominant epitope of the strains collected in that year.
The standard deviations of the numbers of charged amino
acid on the dominant epitope were also calculated for each
year. Again, there is no assurance that any of these muta-
tions can be considered end-point or ﬁxed variants as the
evolutionary process continued from year to year. By using
these Pc t j  ;d;Pc0 ðÞ to ﬁt the parameters h ¼  ;d;Pc0 ðÞ ,  
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Fig. 4 Number of charged amino acids for each year on the dominant
epitopes of the circulating strains. Both the observed data from 1971
to 2003 and the predicted data from 1972 to 2003 are plotted. Since
the estimated Pc0 was close to the observed number, we used the
observed numbers of charged amino acids in the ﬁrst year of the
interval to calculate Pc0
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123approached to zero when the number of iterations of the
ﬁtting algorithm increased to inﬁnity, while the product  d
approached to 0.016 compared with the product  d = 0.023
in the case with only circulating strains. Both the calculated
and observed Pc0 equal to 0.14. The model ﬁt well with all
the datapoints in this time span with R
2 = 0.99. We note
that the Markov model is not able to reproduce convex and
rising data, and this is the reason for   ? 0 for these data. In
fact the data in Fig. 5 are convex probably because the
simple arithmetic averaging is only a rough approximation,
and we expect concave and rising data, which the Markov
model can represent, from a properly weighted population
average. The maximum likelihood method estimated the
same parameter values to within two signiﬁcant ﬁgures as
the least square ﬁtting method.
The continuous-time Markov chain possessed the simi-
lar parameter set h ¼ k1;k2;Pc0 ðÞ to the discrete-time
Markov chain. For the circulating strains in 1972–1987, the
nonlinear least-squares ﬁtting yielded the parameters k1 ¼
0:15;k2 ¼ 0:084;Pc0 ¼ 0:094 with R
2 = 0.98. For the
database strains, there were k1 ¼  0:031;k2 ¼ 0:011;
Pc0 ¼ 0:14 with R
2 = 0.99. As before, simple arithmetic
averaging produces convex and rising data, which the
Markov model is not able to represent, and which is not
expected from a population average.
The RAMM model ﬁt well the data in circulating strains
and those in the GenBank database in the ﬁrst time interval
(1972–1987). This model had a larger discrepancy in the
prediction versus both groups of data in the second
(1989–1995) and third time interval (1996–2003).
Evolution of Amino Acids in Epitopes
of Hemagglutinin Is Non-Universal: Comparison
with PAM Matrix
To compare with the RAMM model, we also employed the
conventional PAM matrix (Dayhoff et al. 1978) to predict
the evolution of charged amino acids. We ﬁrst calculated
the PAM1 matrix M = {Mij} describing the evolution of
one amino acid position during a time unit in which the
probability that a point mutation occurred in this position
was ﬁxed by Dayhoff et al. (1978) to 0.01 (the meaning of
the sufﬁx 1). Evolution during n time units was depicted by
PAMn matrix with PAMn ¼ PAM1n ¼ Mn ¼f M0
ijg. The
probability for a point mutation occur was then
P ¼
X 20
i¼1
1   M0
ii
  
pi: ð11Þ
We let this probability equal to the annual mutation rate
calculated by the RAMM model and veriﬁed by the
historical data, 19 /20 = 0.196, and so PAM22 should be
selected to calculate the mutations during 1 year. The more
frequently used PAM20 matrix, however, underpredicts the
annual mutation rate and generates larger errors. While the
PAM22 matrix reproduces the observed number of total
mutations in the dominant epitope, as we shall see, it
underpredicts the number of charged mutations per year.
This means there is an additional selective force for
charged amino acids in the epitopes of hemagglutinin
relative to protein evolution in general. To calculate the
2   2 transition matrix with the deﬁnition
P ¼
Pcc Pcu
Puc Puu
  
there were
Pcu ¼ Pfcharged ! uncharged j chargedg
¼
P
i¼charged
P
j¼uncharged M0
ij
  
pi
P
i¼charged pi
ð12Þ
Puc ¼
P
i¼uncharged
P
j¼charged M0
ij
  
pi
P
i¼uncharged pi
ð13Þ
Pcc ¼ 1   Pcu ð14Þ
Puu ¼ 1   Puc: ð15Þ
yielding the solution of the transition matrix P based on
PAM22 matrix
P ¼
0:883 0:117
0:040 0:960
  
ð16Þ
which is slightly different from RAMM matrix (10). The
evolution predicted by PAM22 matrix for the circulating
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Fig. 5 Number of charged amino acids for each year on the dominant
epitopes of the average of all the database strains in the same year.
Both the observed data from 1971 to 2003 and the predicted data from
1972 to 2003 were plotted. We used the observed numbers of charged
amino acids in the ﬁrst year of the interval to calculate Pc0. Error bars
for the circulating strains are one standard deviation calculated from
all NCBI strains collected in that year
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123strains and equally weighted database strains is plotted in
Figs. 6 and 7, respectively.
Guinea Pig Animal Model Veriﬁes the Increase
in Charge
To buttress our analyses of the evolution of charged amino
acids in historical virus sequences, we examined the
frequency of charge changes in the HA sequences derived
from the progeny virus using the Guinea pig animal
infection model. The animals were divided into two
groups, naı ¨ve and immune. The immune animals were
either previously infected or immunized with HA protein.
The animals were given either an inoculum of a dominate
strain with the frequency 64.3%, as well as three closely
related variants with the frequencies 14.3, 14.3, and 7.1%
respectively, totaling 35.7%, denoted CDC, or an inoculum
of the dominant plaque-puriﬁed strain of the CDC stock
mentioned above, denoted WyB4. The HA genes from
replicated virus were sequenced from nasal washing sam-
ples at three days following intra-nasal inoculation. As
observed in Table 2, naı ¨ve animals given the CDC inocu-
lum resulted in an increase in the frequency of variants in
the nasal wash virus. The WT:mutant ratio of 64.3%:35.7%
in the CDC inoculum was reduced to 48.3%:51.7% in the
progeny virus, indicating that the dominant viral strain in
the starting material was reduced 16.0% while new HA
mutants increased 16.0%. Moreover, most of the progeny
variants characterized in the nasal wash samples were not
previously detected in the CDC stock virus suggesting that
the progeny variants arose during infection in the Guinea
pig. The Guinea pig animal model also yielded new strains
with multiple mutations as well as new strains which
fundamentally changed the biochemical character of the
mutated amino acid. Although many of the new variants
may came from neutral mutation, the scenario that some of
the new variants increased the replicative ﬁtness cannot be
precluded. Thus, it seems likely that the egg-adapted
variants in the CDC stock had reduced replicative ﬁtness
relative to the WyB4 strain. Unexpectedly, reinfection of
the same Guinea pigs with the CDC stock resulted in an
increase of 11.3% in the frequency of the wildtype HA
sequence and a concomitant equal decrease in the fre-
quency of progeny strains having mutated HA genes.
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Fig. 6 Number of charged amino acids for each year on the dominant
epitopes of the circulating strains. Both the observed data from 1971
to 2003 and the predicted data from 1972 to 2003 with PAM22 matrix
were plotted. Pc0 was ﬁxed to the observed numbers of charged amino
acids in the ﬁrst year of the interval. The PAM22 matrix cannot
reproduce the data
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Fig. 7 Number of charged amino acids for each year on the dominant
epitopes of the average of all the database strains in the same year.
Both the observed data from 1971 to 2003 and the predicted data from
1972 to 2003 with PAM22 matrix were plotted. Pc0 was ﬁxed to the
observed numbers of charged amino acids in the ﬁrst year of the
interval. The PAM22 matrix cannot reproduce the data. Error bars for
the circulating strains are one standard deviation calculated from all
NCBI strains collected in that year
Table 2 Sequence analysis of progeny virus isolated from nasal
washes of infected Guinea pigs
Virus Immune
status
Number of
sequences
Wild type Mutants
CDC Naı ¨ve 58 28 (48.3%) 30 (51.7%)
CDC Reinfected 82 62 (75.6%) 20 (24.4%)
WyB4 Naı ¨ve 62 43 (69.4%) 19 (30.6%)
WyB4 HA-immunized 210 159 (75.7%) 51 (24.3%)
CDC virus designates mixture of Wyoming HA sequence variants
contained in initial virus stock. WyB4 virus designates puriﬁed stock
from predominant isolate of CDC virus. Immune status refers to
whether the animals were naı ¨ve, i.e., neither previously infected nor
immunized with puriﬁed HA protein, or immune. Number of
sequences refers to the number of HA genes examined in progeny
virus isolated from nasal washes
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123In the second set of experiments in which naı ¨ve Guinea
pigs were infected with the WyB4 plaque-puriﬁed clone of
the dominant strain in the CDC stock, progeny virus had a
69.4%:30.6% WT:mutant HA gene ratio relatively close to
that seen with the CDC stock in naı ¨ve animals. In the third
experiments in which immunized animals were infected
with the WyB4 virus, the ratio of WT:mutant HA genes
increased to 75.7%:24.3%, similar to the result observed in
infections with the CDC stock. Taken together, infection of
naı ¨ve animals resulted in a frequency of WT HA genes of
approximately 65–70% while infection of immune animals
produced an increase in the WT frequency to *76%
regardless of whether the CDC stock or WyB4 virus was
used. By comparing the percentages of mutants listed in
Table 2, three pairs of numbers are statistically signiﬁ-
cantly different (p\0.02), which are CDC naı ¨ve vs. CDC
reinfected, CDC naı ¨ve vs. WyB4 naı ¨ve, and CDC naı ¨ve vs.
WyB4 HA-immunized, respectively. The null hypothesis
cannot be rejected for the other three pairs when testing the
statistically signiﬁcant difference (p[0.3). That is, only
the low WT ratio in CDC naı ¨ve is statistically signiﬁcant.
Presumably the immunized animals eliminated the virus
more quickly, and so fewer mutations were formed.
Figure 8 compares the number of charged residues
predicted by both the PAM22 model and the reduced
alphabet Markov model (RAMM), with those observed in
the progeny of Guinea pigs infected with the A/Wyoming/
2003 mixture obtained from the CDC. Because epitope B
was the dominant epitope in the Wyoming virus circulating
in 2003, we focused our analysis on the residues contained
within this epitope. Five charged residues were present in
the 21 amino acid B epitope in the initial Wyoming inoc-
ulum. The mean number of charged residues increased to
5.09 in the progeny from naı ¨ve animals and 5.09 in the
progeny of reinfected animals.
The evolutionary times between the strains from the
original inocula, the progeny of naı ¨ve Guinea pigs, and the
progeny of reinfected animals are estimated by the mean
number of mutations in the whole sequence of strains
collected from Guinea pigs, divided by the approximate
annual historical number of mutations in the whole HA1
sequences (mean historical mutations during the years
1971–2003 = 5.2 amino acids/HA1 sequence/year). Note
that regardless of whether charged amino acids are
involved, the numbers of mutations in the whole sequence
instead of epitope B are used to calibrate the evolutionary
times. The strains from the naı ¨ve Guinea pig experiments
were characterized, and the total number of point mutations
in these strains was then divided by the number of strains to
calculate the population average number of point mutations
in the progeny strains. This average number was divided by
5.2, the mean number of historical mutations per year in the
whole HA1 sequences, to obtain the evolutionary time Dt
for the naı ¨ve Guinea pig experiment. The Dt for the rein-
fection experiment was calculated following the same
method. The number of charged amino acids in epitope B,
the dominant epitope for the Wyoming strain, increased in
a trajectory that closely followed the path predicted by the
RAMM model. In contrast the generic protein evolution
PAM22 model predicted no such increase in charged res-
idues. The evolutionary times and the numbers of charged
amino acids in epitope B are calculated respectively by
different approaches, therefore the evolutionary time is
independent of the increase of charged amino acids. Thus,
the agreement between RAMM model and the experiment
is nontrivial.
Figure 9 shows a similar plot of charged residues
observed from the experimental infection of naı ¨ve and
immune Guinea pigs with the WyB4 isolate compared to
predicted values. The methods used in the analysis shown
in Fig. 8 were applied to the data derived from infection
with the homogenous virus. The WyB4 appeared to accu-
mulate charged residues in the epitope B somewhat more
rapidly than the Wyoming mixture obtained from the CDC.
These data suggest either that the WyB4 strain has a rep-
licative advantage in Guinea pigs and therefore evolves
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Fig. 8 Comparison of charged residue changes between theoretical
models and sequence data derived from Guinea pigs inoculated with
the CDC A/Wyoming/2003 virus mixture. The RAMM and the PAM
theoretical models were considered, as well as three data points from
the Guinea pig infections: First point: Wyoming inoculum; Second
point: progeny strains from infection of naı ¨ve Guinea pigs; and Third
point: progeny strains from infection of previously infected Guinea
pigs. The time of naı ¨ve and reinfection strains was estimated from the
average number of amino acid mutations, counting both wild type and
mutated strains, in the whole HA1 sequence. With the assumption
derived from historical data that the annual mutation rate was 5.2
amino acids/HA1 sequence/year, we divided those average numbers
of mutations by 5.2 to obtain the times. Error bars are one standard
error
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123faster, or that accumulation of charged residues, especially
in immune animals, represents a selective advantage.
Comparing Figs. 8 and 9, the WyB4 isolate appeared
to evolve more in naı ¨ve animals than did the mixed CDC
stock. A greater number of mutations per mutant strain
were observed in naı ¨ve animals receiving the WyB4
isolate virus than the naı ¨ve animals receiving the CDC
swarm. Among the 30 collected mutants of CDC naı ¨ve,
the numbers of mutants with 1–4 point mutations were
22, 3, 4, and 1, respectively, with the average number of
mutations per mutant equaled 1.47 (standard error: 0.16),
and 15 of 44 (34.1%) mutations occurred in epitopes
A–E. Among the 19 collected mutants of WyB4 naı ¨ve,
the number of mutants with 1–4 point mutations were 6,
10, 2, and 1, respectively, with the average number of
mutations per mutant equaled 1.89 (standard error: 0.19),
and 21 of 36 (58.3%) mutations occurred in epitopes
A–E. The difference of the average number of mutations
per mutant of CDC naı ¨ve and WyB4 naı ¨ve is hence
signiﬁcant (p ¼ 0:039). Again, the mechanisms behind
these data are not clear, but they suggest the appearance
of some form of heterotypic immunity in the CDC stock
virus. That is, the immune system of the Guinea pig either
put more pressure on the WyB4 strain to evolve or took
longer to clear the WyB4 and so allowed it to evolve
longer relative to the CDC stock virus. An estimation of
evolutionary time from the total number of mutations in
the HA protein suggests the explanation is more likely the
former.
Partitioning the Amino Acids by Charge is Optimal
The RAMM model discussed in this paper deals with the
numbers of amino acids belonging to a certain category in
different years. Besides the charged–uncharged categori-
zation of the 20 amino acids, we considered six different
categories, which were polar (Arg, Asn, Asp, Cys, Glu,
Gln, His, Lys, Ser, Thr, Tyr), hydrophobic (Ala, Gly, Ile,
Leu, Met, Phe, Pro, Trp, Val), basic (Arg, Lys, His), acidic
(Asp, Glu), amides (Asn), aliphatic (Gly, Ala, Val, Leu,
Ile), to generate different data sets for the RAMM model.
Four combinations among these seven categories were also
introduced with the amino acids in each category being
counted once, which were charged ? basic, charged ?
acidic, charged ? polar, hydrophobic ? aliphatic, respec-
tively. To further generalize the R
2 value given by the
RAMM model, different combinations of epitopes were
focused on. Here the sequence of H3 hemagglutinin (HA1)
between position 44 and 312 was split into six subsets:
epitope A–E, and the amino acids outside any epitope,
deﬁned as O. Table 3 shows that charged amino acids are
among the categories best ﬁt by the RAMM model. Table 4
lists the R
2 values of the RAMM model for seven cate-
gories of amino acids that are counted in six combinations
of epitopes containing epitope B, the dominant epitope in
the year of 1972–1987. Compared with Table 3, Table 4
indicates that focusing on the dominant epitope leads to the
approximately optimal ﬁtting.
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Fig. 9 Comparison of charged residue changes between theoretical
models and sequence data derived from progeny virus isolated from
Guinea pigs inoculated with the homogeneous WyB4 virus isolate.
The number of predicted and observed charged residues were
analyzed with the method used for the data in Fig. 8. Error bars are
one standard error
Table 3 R
2 values for amino acid categories and epitope B, the
dominant epitope, using dominant circulating strains in 1972–1987
from which the model is trained
Categories R
2
Charged 0.9810
Polar 0.9620
Hydrophobic 0.9586
Basic 0.9872
Acidic 0.8743
Amides 0.6217
Aliphatic 0.7698
Combinations
Charged ? Basic 0.9932
Charged ? Acidic 0.9567
Charged ? Polar 0.9568
Hydrophobic ? Aliphatic 0.8528
Seven categories and four combinations of categories are presented
here. These four combinations involving charged and hydrophobic
amino acids are chosen as the supplement to the seven categories,
because charged and hydrophobic amino acids, especially charged
ones, are critical in protein–protein interaction and evolution
(Clackson and Wells 1995; Nakajima et al. 2007; Sinha et al. 2002;
Kaverin et al. 2000; Leunissen et al. 1990)
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Data Fitting and Verifying the RAMM Model
For the historical data, our analysis was based on both the
dominant circulating strain and the average of all circu-
lating strains deposited in NCBI database. The frequency
of database strains is not currently available. In addition,
because clear sequential and temporal relationships
between the sequences are unavailable, the ﬁxation of
mutations is unknown. Although some trends in the
mutations have emerged (such as increased numbers of
both charged residues in deﬁned epitopes and total num-
bers of glycosylation sites throughout the HA ectodomain),
the majority of the sequences do not appear to be ﬁxed.
For the Guinea pig animal model, the frequency of both
wildtype and variants were collected and tabulated. These
data allowed us to calculate a population average of all the
strains with no loss of frequency information when
counting the average number of mutations and the increase
of charged amino acids. For the Guinea pig experiment, we
have sequences for all the strains characterized in all ani-
mals, and can thus calculate the true population average.
However, at this time we do not have ﬁrm data on ﬁxation
rates of variants in the Guinea pig infection. Some of the
observed variants could have been ﬁxed over the 4–6
rounds of replication that occurred in the three-day infec-
tion, but a serial transmission experiment performed in
immune animals would be required to provide quantitative
data on mutations have become immunologically ﬁxed.
Thus, the quality of the Guinea pig data and the human
database with respect to ﬁxation of mutations is compara-
bly similar.
Note the RAMM model calibrated to years of human
epidemiological data ﬁt well the Guinea pig experimental
data. Figures 8 and 9 compare the observed evolution of
the HA envelope in the CDC Wyoming mixed stock and
the puriﬁed WyB4 isolate with the evolution predicted by
the two models. As shown above, the model ﬁt the in vivo
data well for the CDC stock but underestimated the accu-
mulation of charged residues observed in progeny from the
WyB4 infections. CDC stock was an ensemble of a dom-
inant and three closely related variants while WyB4, the
plaque-puriﬁed isolate and the dominant member of the
CDC stock was the virus that appeared to have greater
replicative capacity in Guinea pigs as compared to the
variants in the CDC stock. The CDC stock infection of
naı ¨ve animals more closely represents a cross-section of a
transmitting quasi-species related to all the circulating
strains existing in 1 year, while the WyB4 infection of
naı ¨ve animals may model the dominant circulating strain.
Table 4 provides further support to the hypothesis of a
single dominant epitope. These data show the R
2 values of
the correlations between observations and the model using
numbers of charged amino acids in a variety of combina-
tions of epitopes as well as a general null model using the
whole sequence of H3 HA. Different amino acid categories
are also incorporated in Table 4 to show the R
2 values of
the correlation between observations and the model. Thus,
as in previous studies (Sun et al. 2006), Table 4 conﬁrms
that calculations using the single dominant epitope lead to
the approximately optimal ﬁtting between the observations
and the model. None of the inclusions of subdominant
epitopes yields R
2 values much greater than that of
focusing on the single dominant epitope.
The results obtained from the discrete-time and contin-
uous-time Markov chains were essentially identical. By
comparing expressions (3) and (7), the parameter set of the
discrete-time Markov chain  ;d;Pc0 ðÞ and that of the
continuous-time Markov chain k1;k2;Pc0 ðÞ are related by
  ¼ 1   e  k1þk2 ðÞ
d ¼ k2
k1þk2   1
4
 
ð17Þ
The discrete-time Markov chain was appropriate for the
case in this paper because the time unit for the data was
year. Currently there is limited time resolution available,
hence using discrete-time model with 1-year time resolution
did not lose any information. The virus evolves continu-
ously in different geographic regions, however, and spreads
among these regions by the migration of humans and birds.
Furthermore, the global virus strains in a given time point
constitutes an ensemble where the population of different
strains varies. Available data are the dominant circulating
strains in each year, as well as the database strains. There-
fore, the average numbers of charged amino acids should be
the weighted sum of all the database strains in each year,
Table 4 R
2 values for amino acid categories and combinations of
epitopes involving epitope B, the dominant epitope, using dominant
circulating strains in 1972–1987 from which the model is trained
Epitopes AB BC BD BE BO ABCDEO
Charged 0.8928 0.9782 0.9431 0.9913 0.9810 0.8935
Polar 0.8187 0.9620 0.7780 0.8528 0.9766 0.7656
Hydrophobic 0.9586 0.9771 0.7928 0.9580 0.9884 0.9766
Basic 0.9872 0.9872 0.9913 0.9456 0.9872 0.9917
Acidic 0.4730 0.9210 0.6337 0.7245 0.6838 0.3916
Amides 0.9771 0.7922 0.9834 0.2171 0.8443 0.9326
Aliphatic 0.4976 0.9009 0.7648 0.3787 0.7895 0.6129
Residues outside an epitope are denoted by O. The dominant circu-
lating strains in the time span of 1972–1987 have epitope B as the
dominant epitope. The H3N2 virus emerged in 1968, therefore less
adaptation to host immune system was developed compared with
other time span. The previous discussion indicates that epitope B had
the immunodominance in this period of time, and this table shows the
limited contribution of amino acids outside the dominant epitope to
the pattern of evolution
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signiﬁcant help to know the frequency of each database
strain so that a population average can be calculated.
Model Reversibility
Most previous models assumed the reversibility of the
Markov chain, whose transition matrices P = {Pij} and
equilibrium probability distributions p ¼f pig satisﬁed the
detailed balance equation
piPij ¼ pjPji: ð18Þ
Such models were mainly designed to describe the evolu-
tion of bacteria, archaea, and eukaryota living in a relative
constant environment. The evolution of these species is
probably dominated by a stable and loose natural selection
that is tolerant to mildly deleterious polymorphism
(McDonald 2006). Viruses, on the other hand, perform
their biological function in other organisms, and usually
their surface protein antigens are targeted by the immune
systems in the antigen sequence space that makes the virus
evolution under strong, directed, and changing selection.
This arrow of time due to directed selection invalidates the
reversibility assumption, because p is changing, and this
higher degree of freedom must be accounted for when
formulating the model. In the data shown here, the detailed
balance condition (18) was not established, because the
immune pressure and selection are constantly changing. In
other words, when starting from a non-steady state initial
condition, the system will ﬁrst converge toward the steady
state before ﬂuctuating about that steady state until the
immune pressure changes again. We studied the non-
equilibrium dynamics of the evolution: the evolution of the
probability distribution was dominated by a changing
proportion of charged amino acids.
Compared with Figs. 4 and 5, PAM22 ﬁt better with
both the circulating strains and the database in later years
than in early years partly because the equilibrium proba-
bility distribution of PAM22 model (16) solved by (18) was
Pc ¼ 0:25;Pu ¼ 0:75, hence the expected numbers of
charged amino acid in epitope A and epitope B were 5.31
and 4.81, close to the numbers in later years depicted in
Figs. 1 and 3. On the other hand, PAM22 drifted away
from both the circulating strains and the database strains in
the early stage after the emergence of H3N2 virus, when
the immune escape was underway most strongly. This
phenomena showed that H3N2 virus did not follow the
general law of protein evolution in a constant environment
in the early years, while its evolution returned to steady
state about 20 years after its emergence in 1968. The higher
ﬁxation rate of charged residues determined by the RAMM
model versus the general PAM model is due to immune
pressure.
Fluctuation and Spatial Distribution of Charge
The dominant epitopes (Gupta et al. 2006) in history were
epitope A and epitope B, so in a certain year one of them
was dominant while the other was subdominant. As a
common trend, the number of charged amino acids on the
dominant epitope increased and that on the subdominant
epitope decreased. The explanation is likely that an
increase in number of charged amino acids reduces the free
energy of binding of antibodies to the epitope, by
increasing the afﬁnity of the epitope for water. Although
the number of charged amino acid on the subdominant
epitope decreased almost monotonically, it never decreased
to the initial level.
Nakajima et al. (2007) pointed out that the epitopes of
A/Aichi/2/1968 and A/Kamata/14/1991 share similar
shapes, hence the spatial distribution of charged amino
acids on the epitopes could be estimated from the available
structure of Aichi strains in 1968 (PDB entry: 1KEN). We
plotted such ﬁgures for epitope A and B for each circu-
lating strain. The number and position of hydrophobic
amino acids were relatively conservative: hydrophobic
amino acids existed at position (130, 138, 168) on epitope
A and position (163, 194, 196, 198) on epitope B in each
circulating strain. Positions (130, 138, 168) located in three
corners of epitope A while positions (163, 194, 196, 198)
constituted a continuous region on the center of epitope
B. The hydrophobic center on epitope B was gradually
surrounded by charged amino acids during the virus evo-
lution in 1972–1987, so in the epitope shift year of 1989,
epitope B contained a hydrophobic center surrounded by
charged amino acid, a structure found in other protein-
protein interaction cases (Clackson and Wells 1995). This
arrangement of amino acids was preserved in epitope B in
later years, which may be the reason that the number of
charged amino acids stayed in a high level in epitope B.
Epitope A, however, did not evolve into the stable structure
with a hydrophobic center surrounded by charged residues;
thus the number of charged amino acids fell to a lower
level when epitope A was subdominant than when epitope
B was subdominant. We also repeated the same analysis on
the recently emerged H5N1 strains, using as epitopes the
residues aligned to H3N2 epitopes. We did not observe a
signiﬁcant change in the number of charged amino acids,
perhaps since the H5N1 virus has not evolved substantially
in human.
Conclusion
Mutation of the H3 hemagglutinin on the surface of the the
inﬂuenza virus decreases the ability of the immune system
to recognize the ﬂu and decreases the efﬁcacy of the annual
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123vaccine. We show that inﬂuenza tends to increase the
number of charged amino acids in the regions of hemag-
glutinin that the immune system recognizes, probably
because this reduces ability of antibodies to bind hemag-
glutinin. An interesting corollary of this selection is that the
number of charges in the dominant epitope of the dominant
circulating virus strain is never fewer than that in the
vaccine strain, chosen early in the season. We developed a
model of the evolution of charge in hemagglutinin by
partitioning 20 amino acids into two categories: charged
and uncharged, calibrated this model on virus evolution
data in humans, and demonstrated the model on Guinea pig
animal model studies.
Protein evolution models such as PAM model and
BLOSUM model typically apply to the evolution of bac-
teria, archaea, and eukaryota. For inﬂuenza virus, the harsh
and changing environment due to immune pressure on the
virus, makes its evolution a non-equilibrium dynamics,
especially in the time period after its initial emergence in
humans. The RAMM model supports the hypothesis that
the rate of charge evolution is greater in regions of hem-
agglutinin recognized by the immune system than in pro-
teins in general. Such temporal and spatial heterogeneity
requires a method such as we have presented here for
modeling the virus evolution.
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